Skip to content

Effect of Probiotics on Regulating Gut Health and Blood Lipid in Adults

Effect of Probiotics on Regulating Gut Health and Blood Lipid in Overweight and Obese Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06554314
Enrollment
50
Registered
2024-08-15
Start date
2024-05-17
Completion date
2025-05-31
Last updated
2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The purpose of this study was to evaluate the efficacy of 1 capsules (300 mg per capsule) of Nutrarex Probiotic Capsules per day in regulating gut health and blood lipid in adults by clinical trial.

Detailed description

This experiment is carried out in a controlled manner. Before the subjects enter the research experiment, they need to follow their original lifestyle. The habits of maintaining a constant body weight for more than 2 weeks before the test, such as calorie balance in the diet and the amount of activity. Then enter the test to carry out the evaluation test of probiotics to the end. 50 subjects were randomized, 25 to placebo and 25 to probiotics. The subjects took one capsules of Nutrarex probiotics daily, a total of 300 mg. Continue to take it for 4 weeks, and perform blood routine tests. Body composition detection, waist and hip circumference measurement, related index analysis and 24-hour dietary questionnaires, gut health questionnaires and stool samples were collected and analyzed for 4 weeks before and after treatment.

Interventions

DIETARY_SUPPLEMENTprobiotics

Eat a capsule for once, and once a day

Sponsors

Nutrarex Biotech Ltd.
CollaboratorUNKNOWN
Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* male or female participants * aged 20-65 years old * body mass index in 25-27 kg/m2 or body fat \> 25% for men and \> 30% for women

Exclusion criteria

* cancer, chronic heart disease, use drugs which pharmacological effects may affect immunity having systemic infections * using probiotics.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline serum lipids at week 4Week0, Week4Compared the difference of serum lipids level between the week 4 and 0

Countries

Taiwan

Contacts

Primary ContactChin-Lin Hsu, Professor
clhsu@csmu.edu.tw04-24730022

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026